Research Use Only
This information is for educational and research purposes only. Not intended for medical advice or self-medication.
Overview
Experimental protocol based on the exercise mimetic SLU-PP-332 (ERRα/β/γ agonist) for enhancing fat oxidation, increasing endurance, and improving metabolic profile. For preclinical research only.
Peptides Involved
Compare the peptides included in this protocol side by side.
| Typical Dose | |||||
|---|---|---|---|---|---|
| SLU-PP-332 | Experimental | 🏋️Weight Loss | 290.32 Da | — |
Comparing 1 peptide
Dosage Schedule
SLU-PP-332: 50 mg/kg body weight (preclinical mouse doses)
Twice daily, intraperitoneally (in preclinical models)
Cycle Information
Preclinical protocol: 28 days of continuous administration. For ob/ob mice, duration was shortened to 12 days due to tolerability issues. Human cycling has not been established.
Stacking Notes
In studies, SLU-PP-332 was used as monotherapy. Potential combination with a low-calorie diet and moderate aerobic exercise may enhance the metabolic effect. Combination with GLP-1 agonists (semaglutide, tirzepatide) has not been studied.
Warnings & Precautions
FOR RESEARCH PURPOSES ONLY. Not approved for human use. All data from mouse experiments. Human dosages not established. Long-term safety not studied. WADA may classify as a prohibited substance (category S4). Not recommended for athletes.
Research Use Only. This information is for educational and research purposes only. Not intended for medical advice or self-medication.
Frequently Asked Questions
Experimental protocol based on the exercise mimetic SLU-PP-332 (ERRα/β/γ agonist) for enhancing fat oxidation, increasing endurance, and improving metabolic profile. For preclinical research only.
SLU-PP-332: 50 mg/kg body weight (preclinical mouse doses)
Twice daily, intraperitoneally (in preclinical models)
28 days (protocol per Billon et al., 2024)
FOR RESEARCH PURPOSES ONLY. Not approved for human use. All data from mouse experiments. Human dosages not established. Long-term safety not studied. WADA may classify as a prohibited substance (category S4). Not recommended for athletes.